BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 24814181)

  • 21. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
    Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
    PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging.
    Kim S; Jain M; Harris AB; Lee VS; Babb JS; Sigmund EE; Rueff LE; Taouli B
    Radiology; 2009 Jun; 251(3):796-807. PubMed ID: 19380690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.
    Ozturk K; Soylu E; Cayci Z
    Eur J Radiol; 2021 Aug; 141():109784. PubMed ID: 34051685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study.
    Chaganti J; Taylor M; Woodford H; Steel T
    World Neurosurg; 2021 Jul; 151():e979-e987. PubMed ID: 34020062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
    Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
    Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility-weighted imaging (SWI).
    Peters S; Knöß N; Wodarg F; Cnyrim C; Jansen O
    Rofo; 2012 Aug; 184(8):713-8. PubMed ID: 22618484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data-driven grading of brain gliomas: a multiparametric MR imaging study.
    Caulo M; Panara V; Tortora D; Mattei PA; Briganti C; Pravatà E; Salice S; Cotroneo AR; Tartaro A
    Radiology; 2014 Aug; 272(2):494-503. PubMed ID: 24661247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
    Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
    Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter.
    Shim WH; Kim HS; Choi CG; Kim SJ
    PLoS One; 2015; 10(7):e0134761. PubMed ID: 26225937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric MRI With Dynamic Contrast Enhancement, Diffusion-Weighted Imaging, and 31-Phosphorus Spectroscopy at 7 T for Characterization of Breast Cancer.
    Schmitz AM; Veldhuis WB; Menke-Pluijmers MB; van der Kemp WJ; van der Velden TA; Kock MC; Westenend PJ; Klomp DW; Gilhuijs KG
    Invest Radiol; 2015 Nov; 50(11):766-71. PubMed ID: 26135017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
    AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma.
    Nakagawa M; Nakaura T; Namimoto T; Kitajima M; Uetani H; Tateishi M; Oda S; Utsunomiya D; Makino K; Nakamura H; Mukasa A; Hirai T; Yamashita Y
    Eur J Radiol; 2018 Nov; 108():147-154. PubMed ID: 30396648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum.
    Horger M; Fenchel M; Nägele T; Moehle R; Claussen CD; Beschorner R; Ernemann U
    AJR Am J Roentgenol; 2009 Nov; 193(5):1384-7. PubMed ID: 19843757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
    Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
    Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
    Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
    World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.